Following the 2022 launch of proXimity, we have focused on advancing and optimizing our platform, and we are now ready to transition into full commercial rollout.
During the initial launch stage, proXimity experienced rapid adoption by researchers and clinicians. At this time, proXimity is:
-
working with 15 CROs, including 80% of the Top 10 CROs
-
the data transfer tool at over 250 trial sites
- automating data transfer for over 160 active trials, with over 650,000 data elements transferred to date
A whitepaper, co-authored by representatives from NEXT Oncology, Precision for Medicine, and Equicare Health has been published, as a case study, and call to action, for the advance of technical solutions to support automated data transfer in clinical trials.
Read more about early proXimity adopters in our customer news archive.